Fig. 2

Results of patients with allo-HSCT who also achieved negative MRD after3 chemotherapy cycles according to TBI and non-TBI conditioning regimens. (A) overall survival, (B) leukemia-free survival, (C) relapse incidence and (D) non-relapse mortality.